Biblio

Export 795 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
S. Baiardi, Capellari, S., Ladogana, A., Strumia, S., Santangelo, M., Pocchiari, M., and Parchi, P., “Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings.”, J Alzheimers Dis, vol. 50, no. 2, pp. 465-76, 2016.
H. Hampel, Toschi, N., Babiloni, C., Baldacci, F., Black, K. L., Bokde, A. L. W., Bun, R. S., Cacciola, F., Cavedo, E., Chiesa, P. A., Colliot, O., Coman, C. - M., Dubois, B., Duggento, A., Durrleman, S., Ferretti, M. - T., George, N., Genthon, R., Habert, M. - O., Herholz, K., Koronyo, Y., Koronyo-Hamaoui, M., Lamari, F., Langevin, T., Lehéricy, S., Lorenceau, J., Neri, C., Nisticò, R., Nyasse-Messene, F., Ritchie, C., Rossi, S., Santarnecchi, E., Sporns, O., Verdooner, S. R., Vergallo, A., Villain, N., Younesi, E., Garaci, F., and Lista, S., “Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.”, J Alzheimers Dis, vol. 64, no. s1, pp. S47-S105, 2018.
M. Vassilaki, Crowson, C. S., Iii, J. M. Davis, Duong, S. Q., Jones, D. T., Nguyen, A., Mielke, M. M., Vemuri, P., and Myasoedova, E., “Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
H. Ulugut Erkoyun, van der Lee, S. J., Nijmeijer, B., van Spaendonk, R., Nelissen, A., Scarioni, M., Dijkstra, A., Samancı, B., Gürvit, H., Yıldırım, Z., Tepgeç, F., Bilgic, B., Barkhof, F., Rozemuller, A., van der Flier, W. M., Scheltens, P., Cohn-Hokke, P., and Pijnenburg, Y., “The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1195-1201, 2021.
A. S. Bukhbinder, Ling, Y., Hasan, O., Jiang, X., Kim, Y., Phelps, K. N., Schmandt, R. E., Amran, A., Coburn, R., Ramesh, S., Xiao, Q., and Schulz, P. E., “Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1061-1074, 2022.
B. Lebwohl, Luchsinger, J. A., Freedberg, D. E., Green, P. H. R., and Ludvigsson, J. F., “Risk of dementia in patients with celiac disease: a population-based cohort study.”, J Alzheimers Dis, vol. 49, no. 1, pp. 179-85, 2016.
B. E. Gavett, John, S. E., Gurnani, A. S., Bussell, C. A., and Saurman, J. L., “The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 531-45, 2016.
H. - Y. Chen and Panegyres, P. K., “The Role of Ethnicity in Alzheimer's Disease: Findings From The C-PATH Online Data Repository.”, J Alzheimers Dis, vol. 51, no. 2, pp. 515-23, 2016.
C. Fenoglio, Scarpini, E., Serpente, M., and Galimberti, D., “Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 62, no. 3, pp. 913-932, 2018.
B. Su Mee Hui, Zhi, L. Rui, Retinasamy, T., Arulsamy, A., Law, C. Shing Wei, Shaikh, M. Farooq, and Yeong, K. Yoon, “The Role of Interferon-α in Neurodegenerative Diseases: A Systematic Review.”, J Alzheimers Dis, vol. 94, no. s1, pp. S45-S66, 2023.
W. J. Streit, Khoshbouei, H., and Bechmann, I., “The Role of Microglia in Sporadic Alzheimer's Disease.”, J Alzheimers Dis, vol. 79, no. 3, pp. 961-968, 2021.
N. Iwahara, Hisahara, S., Kawamata, J., Matsumura, A., Yokokawa, K., Saito, T., Fujikura, M., Manabe, T., Suzuki, H., Matsushita, T., Suzuki, S., and Shimohama, S., “Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1235-1247, 2017.
M. Alegret, Peretó, M., Pérez, A., Valero, S., Espinosa, A., Ortega, G., Hernandez, I., Mauleón, A., Rosende-Roca, M., Vargas, L., Rodríguez-Gómez, O., Abdelnour, C., Berthier, M. L., Bak, T. H., Ruiz, A., Tárraga, L., and Boada, M., “The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 611-619, 2018.
X. - Y. He, Isaacs, C., and Yang, S. - Y., “Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 665-673, 2018.
A. Shelef, Barak, Y., Berger, U., Paleacu, D., Tadger, S., Plopsky, I., and Baruch, Y., “Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.”, J Alzheimers Dis, vol. 51, no. 1, pp. 15-9, 2016.
E. Lacorte, Ancidoni, A., Zaccaria, V., Remoli, G., Tariciotti, L., Bellomo, G., Sciancalepore, F., Corbo, M., Lombardo, F. L., Bacigalupo, I., Canevelli, M., Piscopo, P., and Vanacore, N., “Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.”, J Alzheimers Dis, vol. 87, no. 1, pp. 101-129, 2022.
J. Bennett, Burns, J., Welch, P., and Bothwell, R., “Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1179-87, 2016.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., “Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study.”, J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
X. Hua, Church, K., Walker, W., L'Hostis, P., Viardot, G., Danjou, P., Hendrix, S., and Moebius, H. J., “Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
S. Takenoshita, Terada, S., Yokota, O., Kutoku, Y., Wakutani, Y., Nakashima, M., Maki, Y., Hattori, H., and Yamada, N., “Sally-Anne Test in Patients with Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1029-1036, 2018.
R. O'Caoimh, Timmons, S., and D Molloy, W., “Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments.”, J Alzheimers Dis, vol. 51, no. 2, pp. 619-29, 2016.
E. M. Arroyo-Anlló, Bouston, A. Turpin, Fargeau, M. - N., Baz, B. Orgaz, and Gil, R., “Self-Consciousness in Patients with Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1021-9, 2016.
C. LoBue, Denney, D., Hynan, L. S., Rossetti, H. C., Lacritz, L. H., Hart, J., Womack, K. B., Woon, F. L., and C Cullum, M., “Self-Reported Traumatic Brain Injury and Mild Cognitive Impairment: Increased Risk and Earlier Age of Diagnosis.”, J Alzheimers Dis, vol. 51, no. 3, pp. 727-36, 2016.
O. Elkana, Eisikovits, O. Reichman, Oren, N., Betzale, V., Giladi, N., and Ash, E. L., “Sensitivity of Neuropsychological Tests to Identify Cognitive Decline in Highly Educated Elderly Individuals: 12 Months Follow up.”, J Alzheimers Dis, vol. 49, no. 3, pp. 607-16, 2016.
I. Yasue, Matsunaga, S., Kishi, T., Fujita, K., and Iwata, N., “Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators.”, J Alzheimers Dis, vol. 50, no. 3, pp. 733-40, 2016.

Pages